Background: A PBPK model allows the prediction of the concentration of drug amounts in different tissues and organs over time and can be used to simulate and optimize different therapeutic protocols in healthy and sick individuals. The objective of this work was to create a PBPK model to predict propofol doses for healthy canines and canines with hepatic impairment. Methods: The study methodology was divided into two major phases, in which the first phase consisted of creating the PBPK model for healthy canines, and in the second phase, this model was adjusted for canines with hepatic impairment. The model for healthy canines presented good predictive performance, evidenced by the value of the performance measure of the geometric mean fold error that ranged from 0.8 to 1.25, meeting the double error criterion. The simulated regimen for healthy canines, i.e., of 5 mg/kg (administered as a bolus) followed by a continuous infusion at a rate of 0.13 mg/kg/min, was sufficient and ensured that all simulated subjects achieved the target plasma concentration. Canines with 60% and 40% liver function had infusion rate adjustments to ensure that individuals did not exceed the therapeutic window for maintenance of anesthesia. Results: The results presented in this manuscript are suggestive of the effectiveness and practicality of a PBPK model for propofol in canines, with a particular focus on hepatic impairment.
28 June 2024 in Revista de Investigaciones Veterinarias del Perú
The indiscriminate use of antimicrobials led to the emergence of antimicrobial resistance (AMR), so the rational use of these medications becomes extremely necessary. Thus, an alternative is the use of pharmacokinetic/pharmacodynamic (PK/PD) integration, a tool used in human and veterinary medicine, to determine dosing regimen optimization. Optimizing the dosage regimen makes it possible to establish therapies with greater precision and probability of clinical success, in addition to minimizing toxicity and the spread of antimicrobial resistance. PK/PD integration studies are included in the European Medicines Agency (EMA) guidelines for evaluating medical products; however, this tool needs to be more widespread. Additionally, in 2015, the World Health Organization (WHO) established optimizing antimicrobial doses as one of the five critical points to help reduce the spread of AMR, so PK/PD integration can be used for this purpose. Therefore, this review aimed to elucidate the aspects of PK/PD integration in the selection and optimization of dosing regimens to increase awareness of their development and use by veterinary practitioners.
13 December 2024 in Revista Internacional de Extensão da UNICAMP / International Journal of Outreach and Community Engagement
O brincar constitui relevante oportunidade para o desenvolvimento de inúmeras competências e habilidades da criança, consistindo em um direito assegurado legalmente e fundamentado em diversos estudos. Em situação de hospitalização, o acesso à brincadeira pode proporcionar acolhimento, favorecer a assimilação das informações e a adaptação à nova rotina, ajudá-la a lidar com o ambiente desconhecido, com o medo decorrente da separação do núcleo familiar e dos amigos, preparar para procedimentos, além de contribuir para o manejo positivo da recuperação e de possíveis consequência. Assim, este texto tem como objetivo relatar as ações do projeto de extensão “Sopro de ar fresco: é tempo para brincar” que valoriza o brincar livre e o uso do brinquedo terapêutico no contexto da hospitalização infantil. São apresentadas as linhas de atuação do projeto: a primeira voltada à promoção do brincar livre com crianças, adolescentes e suas famílias hospitalizados em unidades de internação pediátricas, e a segunda com foco no brincar com finalidade terapêutica. Considera-se que as ações contribuíram tanto para a capacitação teórico-prática e formação lúdica dos extensionistas como para sua integração ao contexto de hospitalização infantil por meio do brincar.